GB2196851B - Novel galenical retard form - Google Patents

Novel galenical retard form

Info

Publication number: GB2196851B
Authority: GB; United Kingdom
Prior art keywords: retard form; novel galenical; galenical; novel; retard
Prior art date: 1984-06-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

GB8727055A

Other versions

GB8727055D0 (en

GB2196851A (en

Inventor

Wolfgang Czarnecki

Jean Claude Gfeller

Hans Peter Bier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-14

Filing date

1987-11-19

Publication date

1989-06-07

1987-11-19 Application filed by Sandoz AG filed Critical Sandoz AG

1987-12-23 Publication of GB8727055D0 publication Critical patent/GB8727055D0/en

1988-05-11 Publication of GB2196851A publication Critical patent/GB2196851A/en

1989-06-07 Application granted granted Critical

1989-06-07 Publication of GB2196851B publication Critical patent/GB2196851B/en

Status Expired legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

GB8727055A 1984-06-14 1987-11-19 Novel galenical retard form Expired GB2196851B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3422083		1984-06-14
DE3442566		1984-11-22

Publications (3)

Publication Number	Publication Date
GB8727055D0 GB8727055D0 (en)	1987-12-23
GB2196851A GB2196851A (en)	1988-05-11
GB2196851B true GB2196851B (en)	1989-06-07

Family

ID=25822108

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
GB8514855A Expired GB2160100B (en)	1984-06-14	1985-06-12	Novel galenical retard form
GB8727056A Expired GB2196852B (en)	1984-06-14	1987-11-19	Novel galenical retard form
GB8727055A Expired GB2196851B (en)	1984-06-14	1987-11-19	Novel galenical retard form

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
GB8514855A Expired GB2160100B (en)	1984-06-14	1985-06-12	Novel galenical retard form
GB8727056A Expired GB2196852B (en)	1984-06-14	1987-11-19	Novel galenical retard form

Country Status (21)

Country	Link
AT (1)	AT391806B (en)
AU (2)	AU587190B2 (en)
BE (1)	BE902626A (en)
CA (1)	CA1264441A (en)
CY (1)	CY1635A (en)
DE (1)	DE3520184C2 (en)
DK (1)	DK167649B1 (en)
ES (1)	ES8702141A1 (en)
FR (1)	FR2565822B1 (en)
GB (3)	GB2160100B (en)
GR (1)	GR851430B (en)
HK (1)	HK25192A (en)
HU (1)	HU198844B (en)
IE (1)	IE58834B1 (en)
IL (1)	IL75490A0 (en)
IT (1)	IT1200080B (en)
LU (1)	LU85946A1 (en)
NL (1)	NL194389C (en)
NZ (1)	NZ212390A (en)
PT (1)	PT80635B (en)
SE (1)	SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1187751B (en) *	1985-10-15	1987-12-23	Eurand Spa	PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) *	1987-10-02	1989-03-28	Alza Corporation	Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) *	1988-03-24	1989-10-16	Bukh Meditec A/S	Controlled release composition
GR1000270B (en) *	1988-09-30	1992-05-12	Alza Corp	Dose for cardiovascular troubles therapy
DK469989D0 (en) *	1989-09-22	1989-09-22	Bukh Meditec	PHARMACEUTICAL PREPARATION
MX9300110A (en) *	1992-01-13	1994-07-29	Gerhard Gergely	PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) *	1992-01-17	1993-07-22	Alfatec Pharma Gmbh	Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US6726930B1 (en)	1993-09-09	2004-04-27	Penwest Pharmaceuticals Co.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) *	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) *	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) *	1993-09-14	1995-03-15	Euro Celtique Sa	Laxative compositions in capsules
JP3148256B2 (en)	1996-07-08	2001-03-19	エドワードメンデルカンパニー．，インコーポレーテッド	Sustained release matrix for high dose poorly soluble drugs
DE19710009A1 (en) *	1997-03-12	1998-09-24	Knoll Ag	Multi-phase preparation forms containing active ingredients
US6056977A (en)	1997-10-15	2000-05-02	Edward Mendell Co., Inc.	Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en)	1998-03-10	2004-09-07	Abbott Laboratories	Multiphase active ingredient-containing formulations
EP1189599A2 (en) *	1999-06-11	2002-03-27	Eli Lilly And Company	Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en)	1999-06-11	2006-02-21	Purdue Research Foundation	Pharmaceutical materials and methods for their preparation and use
WO2001010466A1 (en) *	1999-08-04	2001-02-15	Yamanouchi Pharmaceutical Co., Ltd.	Stable medicinal compositions for oral use
DE60038536T2 (en)	1999-09-30	2009-06-10	Penwest Pharmaceuticals Co.	MATRIX SYSTEM WITH DELAYED RELEASE FOR HIGHLY SOLUBLE ACTIVE SUBSTANCES
PT1368006E (en) *	2001-02-13	2006-08-31	Astrazeneca Ab	NEW MODIFIED LIBERTACAO FORMULA
US7135436B2 (en)	2003-05-05	2006-11-14	J.F. Daley International, Ltd.	Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en)	2005-02-11	2006-08-16	Abbott GmbH & Co. KG	Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
US8399007B2 (en)	2006-12-05	2013-03-19	Landec Corporation	Method for formulating a controlled-release pharmaceutical formulation
US8956602B2 (en)	2006-12-05	2015-02-17	Landec, Inc.	Delivery of drugs
US8114883B2 (en)	2007-12-04	2012-02-14	Landec Corporation	Polymer formulations for delivery of bioactive materials
CA2734646C (en)	2008-08-20	2016-06-28	James W. Mcginity	Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617362A1 (en) *	1967-11-17	1971-03-25	Beiersdorf Ag	Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) *	1974-01-09	1982-04-22	Bayer Ag, 5090 Leverkusen	Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) *	1975-10-17	1981-04-02	Sandoz-Patent-GmbH, 7850 Lörrach	Solid substances made from polyvinylpyrrolidone and ergot alkaloids
DE2549740A1 (en) *	1975-11-17	1977-05-18	Sandoz Ag	NEW GALENIC FORMS AND METHODS FOR THEIR PRODUCTION
GB1579818A (en) *	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
DK149855C (en) *	1977-06-20	1987-04-21	Sandoz Ag	METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES
CH639659A5 (en) *	1978-12-18	1983-11-30	Sandoz Ag	NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
EP0001247A1 (en) *	1977-09-14	1979-04-04	Kanebo, Ltd.	Pharmaceutical preparation containing nifedipine and a method for producing the same.
DK154607C (en) *	1978-12-21	1989-06-05	Sandoz Ag	PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
DE2904310A1 (en) *	1979-02-05	1980-08-07	Boehringer Mannheim Gmbh	MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) *	1980-02-20	1981-09-11	Kaken Pharmaceut Co Ltd	Pharmaceutical containing nifedipine
DE3033919A1 (en) *	1980-09-09	1982-04-22	Bayer Ag, 5090 Leverkusen	SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) *	1981-09-02	1984-04-10	Sandoz Ltd.	Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (en) *	1981-10-29	1993-02-10	Bayer Ag	Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) *	1982-10-07	1986-07-29	Kazuo Kigasawa	Soft buccal
DE3318649A1 (en) *	1983-05-21	1984-11-22	Bayer Ag, 5090 Leverkusen	TWO-PHASE FORMULATION

1985
- 1985-05-31 NL NL8501578A patent/NL194389C/en not_active IP Right Cessation
- 1985-05-31 HU HU852126A patent/HU198844B/en unknown
- 1985-06-05 DE DE3520184A patent/DE3520184C2/en not_active Expired - Lifetime
- 1985-06-10 FR FR858508850A patent/FR2565822B1/en not_active Expired
- 1985-06-10 BE BE1/011271A patent/BE902626A/en not_active IP Right Cessation
- 1985-06-12 AT AT0174885A patent/AT391806B/en not_active IP Right Cessation
- 1985-06-12 ES ES544075A patent/ES8702141A1/en not_active Expired
- 1985-06-12 GR GR851430A patent/GR851430B/el unknown
- 1985-06-12 GB GB8514855A patent/GB2160100B/en not_active Expired
- 1985-06-12 IE IE146085A patent/IE58834B1/en not_active IP Right Cessation
- 1985-06-12 NZ NZ212390A patent/NZ212390A/en unknown
- 1985-06-12 PT PT80635A patent/PT80635B/en unknown
- 1985-06-12 IL IL75490A patent/IL75490A0/en not_active IP Right Cessation
- 1985-06-12 AU AU43486/85A patent/AU587190B2/en not_active Ceased
- 1985-06-12 DK DK264785A patent/DK167649B1/en not_active IP Right Cessation
- 1985-06-12 CA CA000483768A patent/CA1264441A/en not_active Expired
- 1985-06-13 IT IT8548210A patent/IT1200080B/en active
- 1985-06-13 LU LU85946A patent/LU85946A1/en unknown
- 1985-06-13 SE SE8502950A patent/SE504583C2/en not_active IP Right Cessation
1987
- 1987-11-19 GB GB8727056A patent/GB2196852B/en not_active Expired
- 1987-11-19 GB GB8727055A patent/GB2196851B/en not_active Expired
1989
- 1989-11-09 AU AU44543/89A patent/AU4454389A/en not_active Abandoned
1992
- 1992-04-02 HK HK251/92A patent/HK25192A/en not_active IP Right Cessation
- 1992-11-06 CY CY1635A patent/CY1635A/en unknown

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NONE *

Also Published As

Publication number	Publication date
SE8502950L (en)	1985-12-15
GB2160100A (en)	1985-12-18
GB2196852B (en)	1989-05-17
GB2160100B (en)	1989-06-01
DE3520184A1 (en)	1985-12-19
DK264785D0 (en)	1985-06-12
DE3520184C2 (en)	1997-03-13
HU198844B (en)	1989-12-28
AU4348685A (en)	1985-12-19
NZ212390A (en)	1992-02-25
DK167649B1 (en)	1993-12-06
CA1264441A (en)	1990-01-16
AU4454389A (en)	1990-03-22
ES544075A0 (en)	1987-01-01
LU85946A1 (en)	1986-01-24
FR2565822A1 (en)	1985-12-20
GR851430B (en)	1985-11-25
GB8727055D0 (en)	1987-12-23
HK25192A (en)	1992-04-10
GB8514855D0 (en)	1985-07-17
ATA174885A (en)	1990-06-15
FR2565822B1 (en)	1989-02-17
CY1635A (en)	1992-11-06
DK264785A (en)	1985-12-15
IL75490A0 (en)	1985-10-31
NL194389C (en)	2002-03-04
BE902626A (en)	1985-12-10
ES8702141A1 (en)	1987-01-01
AU587190B2 (en)	1989-08-10
NL8501578A (en)	1986-01-02
IE58834B1 (en)	1993-11-17
GB8727056D0 (en)	1987-12-23
HUT40918A (en)	1987-03-30
IT8548210A0 (en)	1985-06-13
IE851460L (en)	1985-12-14
IT1200080B (en)	1989-01-05
SE8502950D0 (en)	1985-06-13
GB2196851A (en)	1988-05-11
PT80635B (en)	1987-10-20
GB2196852A (en)	1988-05-11
SE504583C2 (en)	1997-03-10
AT391806B (en)	1990-12-10
NL194389B (en)	2001-11-01
PT80635A (en)	1985-07-01

Publication	Publication Date	Title
GB2160100B (en)	1989-06-01	Novel galenical retard form
PH25083A (en)	1991-02-19	Novel 5-amino-4-hydroxyvaleryl derivatives
GB8519921D0 (en)	1985-09-18	Closures
GB8519922D0 (en)	1985-09-18	Closures
GB2155602B (en)	1988-02-24	Furnace
ZA855092B (en)	1986-02-26	Novel isoindolinyl-alkyl-piperazines
ZA85276B (en)	1986-08-27	Novel 8alpha-acylaminoergolines
GB8522835D0 (en)	1985-10-23	Furnace
EP0191269A3 (en)	1987-08-05	Novel homopropargylamines
GB2159973B (en)	1988-03-23	Microcapsules
EP0178182A3 (en)	1987-07-01	Furnace
NZ212572A (en)	1989-02-24	3-(carboxamidophenoxy)-2-carboxy-7-oxo-4-thia-1-azabicyclo
ZA852440B (en)	1985-11-27	Novel substituted-aminohydroxypropoxy-thiadiazoles
GB2165628B (en)	1987-12-31	Metal-holding furnace
ZA858662B (en)	1986-07-30	Novel 5-amino-4-hydroxyvaleryl derivatives
GB8529207D0 (en)	1986-01-02	Furnace
SG15492G (en)	1992-04-16	Novel galenical retard form
GB8428332D0 (en)	1984-12-19	Mineshaft closures
ZA854520B (en)	1987-02-25	Novel galenic retard form
ZA859831B (en)	1986-09-24	Novel n-actyl-n-isopropylglycine derivatives
ZA858971B (en)	1987-07-29	Novel homopropargylamines
GB2175985B (en)	1988-02-10	Furnace
KR870001568Y1 (en)	1987-04-22	Brick
GR80391B (en)	1984-10-01	Simple form
GB8423461D0 (en)	1984-10-24	Furnace

Legal Events

Date	Code	Title	Description
1997-06-25	732E	Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
2005-07-06	PE20	Patent expired after termination of 20 years	Effective date: 20050611